Introduction
Ceftozom S is a prescription medication that combines two active ingredients: Ceftazidime and Sulbactam. Ceftazidime is an antibiotic from the cephalosporin class, while Sulbactam is a beta-lactamase inhibitor. This combination medication is commonly used to treat various bacterial infections.
Uses
Ceftozom S is primarily prescribed to treat infections caused by susceptible bacteria. It is commonly used for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, and gynecological infections. Note that this medication is only effective against bacterial infections and will not treat viral infections.
Dosage and Administration
Ceftozom S should be administered under the supervision of a healthcare professional. The dosage and duration of treatment will vary depending on the severity of the infection and the patient’s individual factors. It is typically given as an intravenous infusion over a specific period of time. The exact dosage and administration instructions should be determined by the prescribing healthcare provider.
Mechanism of Action
The active ingredients in Ceftozom S work together to combat bacterial infections. Ceftazidime, a cephalosporin antibiotic, inhibits the synthesis of the bacterial cell wall, leading to the destruction of the bacteria. Sulbactam, a beta-lactamase inhibitor, helps to prevent the breakdown of Ceftazidime by certain enzymes produced by bacteria. This combination allows Ceftazidime to remain effective against a broader range of bacteria.
Side Effects
Common side effects may include nausea, vomiting, diarrhea, rash, and injection site reactions such as pain or redness. These side effects are usually mild and temporary. However, if any of these side effects persist or worsen, consult a healthcare professional.
Serious side effects are rare but may include severe allergic reactions, such as difficulty breathing, swelling of the face or throat, and rash. If any of these serious side effects occur, immediate medical attention should be sought.
Drug Interactions
Ceftozom S may interact with other medications, including certain antibiotics, anticoagulants, and medications that affect kidney function. Inform your healthcare provider about all the medications you are taking, including prescription, over-the-counter, and herbal products, to avoid potential interactions. Your healthcare provider will consider these interactions when determining the appropriate treatment plan for you.
Precautions
Before using Ceftozom S, inform your healthcare provider if you have any allergies, especially to antibiotics or other medications. Additionally, inform your healthcare provider about any existing medical conditions, such as kidney problems or a history of gastrointestinal diseases. Ceftozom S may not be suitable for everyone, and your healthcare provider will consider these factors before prescribing this medication.
Storage
Patient Tips
- Follow the dosage and administration instructions provided by your healthcare provider.
- If you experience any side effects, inform your healthcare provider.
- Complete the full course of treatment, even if you start feeling better.
- Do not share this medication with others, as it is prescribed specifically for your condition.
- If you miss a dose, contact your healthcare provider for instructions on how to proceed.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Ceftazidime 1g Powder for Solution for Injection or Infusion (Health Professionals SmPC) Available at:
- Ceftazidime injection (Drugs.com) [Accessed 2 Jun. 2024] (online) Available at:
- ceftazidime sodium in d5w piggyback (RX) [Accessed 11 Jun. 2024] (online) Available at:
- Ceftazidime and Avibactam Injection (MedlinePlus) [Accessed 20 Jun. 2024] (online) Available at:
- Wang Y, Wang J, Wang R, Cai Y. Resistance to ceftazidime-avibactam and underlying mechanisms. J Glob Antimicrob Resist. 2020 Sep;22:18-27. doi: 10.1016/j.jgar.2019.12.009. Epub 2019 Dec 19. [Accessed 8 Jun. 2024] Available at:
Reviews
There are no reviews yet.